| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157034 | American Journal of Kidney Diseases | 2016 | 8 Pages |
Abstract
The serum biomarkers iPTH, whole PTH, and bALP were able to discriminate low from nonlow BFR/BS, whereas iPTH and bALP were able to discriminate high from nonhigh BFR/BS. Prospective studies are required to determine whether evaluating trends in biomarker concentrations could guide therapeutic decisions.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Stuart M. DO, Ezequiel MD, Vanda MD, PhD, Aluizio B. MD, PhD, Hartmut H. MD, AnÃbal MD, PhD, Patrick C. PhD, Tilman B. MD, Hongyan MB, MS, Thomas RN, CRNA, Eudocia MD, Sharon M. MD,